151
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Elevated High Sensitivity Cardiac Troponin T is Nonlinearly Associated with Poor Prognosis in Aging COVID-19 Patients: A Retrospective Study

, , , & ORCID Icon
Pages 5155-5163 | Received 22 May 2023, Accepted 03 Aug 2023, Published online: 09 Aug 2023

References

  • Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on cardiovascular disease. Viruses. 2023;15(2). doi:10.3390/v15020508
  • Ramos-Rincon JM, Buonaiuto V, Ricci M, et al. Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain. J Gerontol a Biol Sci Med Sci. 2021;76(3):e28–e37. doi:10.1093/gerona/glaa243
  • Henkens M, Raafs AG, Verdonschot JAJ, et al. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022;22(1):184. doi:10.1186/s12877-021-02673-1
  • Bonafe M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev. 2020;53:33–37. doi:10.1016/j.cytogfr.2020.04.005
  • Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect. 2020;80(6):e14–e18. doi:10.1016/j.jinf.2020.03.005
  • Amuthavalli Thiyagarajan J, Mikton C, Harwood RH, et al. The UN Decade of healthy ageing: strengthening measurement for monitoring health and wellbeing of older people. Age Ageing. 2022;51(7). doi:10.1093/ageing/afac147
  • Rehatta NM, Chandra S, Sari D, et al. Comorbidities and COVID-19 status influence the survival rate of geriatric patients in intensive care units: a prospective cohort study from the Indonesian Society of Anaesthesiology and Intensive Therapy. BMC Geriatr. 2022;22(1):523. doi:10.1186/s12877-022-03227-9
  • Jansson S, Blixt PJ, Didriksson H, et al. Incidence of acute myocardial injury and its association with left and right ventricular systolic dysfunction in critically ill COVID-19 patients. Ann Intensive Care. 2022;12(1):56. doi:10.1186/s13613-022-01030-8
  • Efros O, Barda N, Meisel E, et al. Myocardial injury in hospitalized patients with COVID-19 infection-Risk factors and outcomes. PLoS One. 2021;16(2):e0247800. doi:10.1371/journal.pone.0247800
  • Chu X, Zhang GF, Zheng YK, et al. Clinical features and risk factors of severely and critically ill patients with COVID-19. World J Clin Cases. 2022;10(3):840–855. doi:10.12998/wjcc.v10.i3.840
  • Ruzzenenti G, Maloberti A, Giani V, et al. Covid and Cardiovascular Diseases: direct and Indirect Damages and Future Perspective. High Blood Press Cardiovasc Prev. 2021;28(5):439–445. doi:10.1007/s40292-021-00464-8
  • Januzzi JL, Mahler SA, Christenson RH, et al. Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(9):1059–1077. doi:10.1016/j.jacc.2018.12.046
  • De Michieli L, Ola O, Knott JD, et al. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clin Chem. 2021;67(8):1080–1089. doi:10.1093/clinchem/hvab062
  • Demir OM, Ryan M, Cirillo C, et al. Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care. Am J Cardiol. 2021;147:129–136. doi:10.1016/j.amjcard.2021.01.037
  • Khaloo P, Shaqdan A, Ledesma PA, et al. Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19. Int J Cardiol. 2022;351:118–125. doi:10.1016/j.ijcard.2021.12.029
  • Lowry MTH, Doudesis D, Wereski R, et al. Influence of Age on the Diagnosis of Myocardial Infarction. Circulation. 2022;146(15):1135–1148. doi:10.1161/CIRCULATIONAHA.122.059994
  • Prokop M, van Everdingen W, van Rees Vellinga T, et al. CO-RADS: a Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97–E104. doi:10.1148/radiol.2020201473
  • Yildirim Ayaz E, Coskun ZU, Kaplan M, et al. Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients with PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives. J Belg Soc Radiol. 2022;106(1):67. doi:10.5334/jbsr.2714
  • Inanc IH, Bursa N, Gultepe A, Bayramoglu M, Sabanoglu C, Inanc FA. Association among CO-RADS score, co-morbid diseases, and short-term prognosis in COVID-19 infection. Eur Rev Med Pharmacol Sci. 2022;26(2):653–663. doi:10.26355/eurrev_202201_27892
  • Villoteau A, Asfar M, Otekpo M, et al. Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients. PLoS One. 2021;16(9):e0256931. doi:10.1371/journal.pone.0256931
  • Maloberti A, Giannattasio C, Rebora P, et al. Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients. Biomedicines. 2022;10(8). doi:10.3390/biomedicines10081940
  • Maloberti A, Ughi N, Bernasconi DP, et al. Heart Rate in Patients with SARS-CoV-2 Infection: prevalence of High Values at Discharge and Relationship with Disease Severity. J Clin Med. 2021;10(23). doi:10.3390/jcm10235590
  • Welsh P, Preiss D, Shah ASV, et al. Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. Clin Chem. 2018;64(11):1607–1616. doi:10.1373/clinchem.2018.292086
  • McCarthy CP, Yousuf O, Alonso A, Selvin E, Calkins H, McEvoy JW. High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease. Am J Cardiol. 2017;119(9):1407–1413. doi:10.1016/j.amjcard.2017.01.032
  • Chesnaye NC, Szummer K, Barany P, et al. Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients. J Am Heart Assoc. 2019;8(21):e013091. doi:10.1161/JAHA.119.013091
  • Chaulin A. Cardiac Troponins: contemporary Biological Data and New Methods of Determination. Vasc Health Risk Manag. 2021;17:299–316. doi:10.2147/VHRM.S300002
  • Maloberti A, Biolcati M, Giannattasio C. Troponin elevation in COVID-19 patients: an important stratification biomarker with still some open questions. Int J Cardiol. 2021;341:107–109. doi:10.1016/j.ijcard.2021.07.049
  • Maino A, Di Stasio E, Grimaldi MC, et al. Prevalence and characteristics of myocardial injury during COVID-19 pandemic: a new role for high-sensitive troponin. Int J Cardiol. 2021;338:278–285. doi:10.1016/j.ijcard.2021.06.028
  • Polcwiartek C, Krogager ML, Andersen MP, et al. Prognostic implications of serial high-sensitivity cardiac troponin testing among patients with COVID-19: a Danish nationwide registry-based cohort study. Am Heart J Plus. 2022;14:100131. doi:10.1016/j.ahjo.2022.100131
  • Menditto A, Protic O, Di Rosa M, Bonfigli AR, Lattanzio F, Antonicelli R. Admission high-sensitivity cardiac troponin levels as a prognostic indicator for in-hospital mortality rates in the elderly and very elderly COVID-19 patients. Arch Gerontol Geriatr. 2023;104:104822. doi:10.1016/j.archger.2022.104822
  • De Marzo V, Di Biagio A, Della Bona R, et al. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. J Geriatr Cardiol. 2021;18(5):338–345. doi:10.11909/j.issn.1671-5411.2021.05.004